Chemokines and chemokine receptors: Positioning cells for host defense and immunity

Annual Review of Immunology

Volumn 32, Issue , 2014, Pages 659-702

  Griffith, Jason W ^a   Sokol, Caroline L ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell migration; Cell trafficking; Chemoattractants; Immune regulation; Inflammation; Lymph node

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

CELL FATE; CELL MIGRATION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHATIC SYSTEM; LYMPHOCYTE DIFFERENTIATION; MEDIATOR; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SECONDARY IMMUNE RESPONSE; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; CELL MOVEMENT; CHEMOKINES; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; LYMPHOID TISSUE; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS;

EID: 84896902938     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032713-120145     Document Type: Review

References (256)

1. Rot A, von Andrian UH. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928
2. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610-21
3. Viola A, Luster AD. 2008. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48:171-97
4. Zlotnik A, Burkhardt AM,Homey B. 2011. Homeostatic chemokine receptors and organ-specificmetastasis. Nat. Rev. Immunol. 11:597-606
5. Love PE, Bhandoola A. 2011. Signal integration and crosstalk during thymocyte migration and emigration. Nat. Rev. Immunol. 11:469-77
6. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. 2003. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 19:257-67
7. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, et al. 2010. The essential functions of adipoosteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33:387-99
8. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, et al. 2005. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201:1307-18
9. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-48
10. Petit I, Szyper-Kravitz M, Nagler A, LahavM, Peled A, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-94
11. Mercier FE, Ragu C, Scadden DT. 2012. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 12:49-60
12. Suratt BT, Petty JM, Young SK, Malcolm KC, Lieber JG, et al. 2004. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 104:565-71
13. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. 2010. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Investig. 120:2423-31
14. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, et al. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34:70-74
15. Gulino AV, Moratto D, Sozzani S, Cavadini P, Otero K, et al. 2004. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections,myelokathexis (WHIM) syndrome. Blood 104:444-52
16. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11:762-74
17. Wang Y, CuiL,Gonsiorek W, Min SH, Anilkumar G, et al. 2009.CCR2andCXCR4regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J. Inflamm. 6:32
18. Serbina NV, Pamer EG. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7:311-17
19. Nie Y,Waite J, Brewer F, SunshineMJ, Littman DR, Zou YR. 2004. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200:1145-56
20. Pereira JP, An J, Xu Y, Huang Y, Cyster JG. 2009. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat. Immunol. 10:403-11
21. Allende ML, Tuymetova G, Lee BG, Bonifacino E,Wu YP, Proia RL. 2010. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J. Exp. Med. 207:1113-24
22. van de Pavert SA, Mebius RE. 2010. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10:664-74
23. Wang H, Beaty N, Chen S, Qi CF, Masiuk M, et al. 2012. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 119:465-68
24. Cyster JG. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127-59
25. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, et al. 2011. The development of inducible bronchus-Associated lymphoid tissue depends on IL-17. Nat. Immunol. 12:639-46
26. Vuillemenot BR, Rodriguez JF, Hoyle GW. 2004. Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor-Alpha. Am. J. Respir. Cell Mol. Biol. 30:438-48
27. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. 2012. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 33:297-305
28. Kreisel D, Nava RG, Li W, Zinselmeyer BH, Wang B, et al. 2010. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc. Natl. Acad. Sci. USA 107:18073-78
29. Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13:159-75
30. Devi S, Wang Y, Chew WK, Lima R, A-GonzalezN, et al. 2013. Neutrophil mobilization via plerixaformediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J. Exp. Med. 210:2321-36
31. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. 2003. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bonemarrow and their return following senescence. Immunity 19:583-93
32. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. 1999. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J. Clin. Investig. 103:1719-27
33. PalframanRT, Collins PD, WilliamsTJ, Rankin SM. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91:2240-48
34. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Investig. 100:1137-43
35. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. 1999. T helper cell type 2 cytokinemediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190:267-80
36. Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, et al. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157:1693-98
37. Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, et al. 2005. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105:4308-13
38. Halova I, DraberovaL,Draber P. 2012. Mast cell chemotaxis- chemoattractants and signaling pathways. Front. Immunol. 3:119
39. Weller CL, Collington SJ, Brown JK,Miller HR, Al-Kashi A, et al. 2005. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 201:1961-71
40. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
41. Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, et al. 2000. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur. J. Immunol. 30:87-97
42. Kurth I,Willimann K, Schaerli P, Hunziker T, Clark-Lewis I,Moser B. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194:855-61
43. Bogunovic M, Ginhoux F, Wagers A, Loubeau M, Isola LM, et al. 2006. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 203:2627-38
44. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B. 2005. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23:331-42
45. Meuter S, Schaerli P, Roos RS, Brandau O, Bosl MR, et al. 2007. Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol. Cell. Biol. 27:983-92
46. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12:495-503
47. VaronaR, Villares R, Carramolino L,Goya I, Zaballos A, et al. 2001. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Investig. 107:R37-45
48. Randolph GJ, Ochando J, Partida-Sanchez S. 2008. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26:293-316
49. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, et al. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-88
50. Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, et al. 2006. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203:519-27
51. Lammermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Soldner R, et al. 2008. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453:51-55
52. GunnMD,Kyuwa S,TamC,KakiuchiT,Matsuzawa A, et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-60
53. Haessler U, Pisano M, Wu M, Swartz MA. 2011. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc. Natl. Acad. Sci. USA 108:5614-19
54. Gatto D, Wood K, Caminschi I,Murphy-DurlandD, Schofield P, et al. 2013. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat. Immunol. 14:446-53
55. CzelothN, Schippers A, Wagner N, MullerW, Kuster B, et al. 2007. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J. Immunol. 179:5855-63
56. Masopust D, Schenkel JM. 2013. The integration of T cell migration, differentiation and function. Nat. Rev. Immunol. 13:309-20
57. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
58. Nakano H, Tamura T, YoshimotoT, YagitaH,MiyasakaM, et al. 1997. Genetic defect inTlymphocytespecific homing into peripheral lymph nodes. Eur. J. Immunol. 27:215-21
59. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, et al. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196:65-75
60. Coelho FM, Natale D, Soriano SF, Hons M, Swoger J, et al. 2013. Naive B-cell trafficking is shaped by local chemokine availability and LFA-1-independent stromal interactions. Blood 121:4101-9
61. Ebisuno Y, Tanaka T, Kanemitsu N, Kanda H, Yamaguchi K, et al. 2003. Cutting edge: the B cell chemokineCXCchemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171:1642-46
62. Schmidt TH, Bannard O, Gray EE, Cyster JG. 2013. CXCR4 promotes B cell egress from Peyer's patches. J. Exp. Med. 210:1099-107
63. Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, et al. 2007. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204:1335-47
64. Lim HW, Broxmeyer HE, Kim CH. 2006. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J. Immunol. 177:840-51
65. Grindebacke H, Stenstad H, Quiding-Jarbrink M, Waldenstrom J, Adlerberth I, et al. 2009. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J. Immunol. 183:4360-70
66. Bernardini G, Gismondi A, Santoni A. 2012. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol. Lett. 145:39-46
67. Peng H, Tian Z. 2014. NK cell trafficking in health and autoimmunity: a comprehensive review. Clin. Rev. Allergy Immunol. In press. doi: 10.1007/s12016-013-8400-0
68. Jenne CN, Enders A, Rivera R,Watson SR, Bankovich AJ, et al. 2009. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206:2469-81
69. Mayol K, Biajoux V, Marvel J, Balabanian K, Walzer T. 2011. Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking. Blood 118:4863-71
70. Maghazachi AA. 2010. Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol. 341:37-58
71. Walker JA, Barlow JL, McKenzie AN. 2013. Innate lymphoid cells-how did we miss them? Nat. Rev. Immunol. 13:75-87
72. Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14:564-73
73. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, et al. 2010. Lineage relationship analysis of RORγt+ innate lymphoid cells. Science 330:665-69
74. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, et al. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171:2571-80
75. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, et al. 2008. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J. Immunol. 181:81-91
76. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, et al. 2002. Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes: strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδT cells. J. Immunol. 168:4920-29
77. Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, et al. 2007. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J. Immunol. 179:1740-50
78. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, et al. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121:4930-37
79. Marshall JS. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4:787-99
80. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107:2613-18
81. Kagnoff MF, Eckmann L. 1997. Epithelial cells as sensors for microbial infection. J. Clin. Investig. 100:6-10
82. Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, et al. 2011. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208:327-39
83. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, et al. 1990. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962-64
84. Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. 2002. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17:413-23
85. Kim HK, De La Luz Sierra M, Williams CK, Gulino AV, Tosato G. 2006. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 108:812-20
86. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, et al. 2009. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10:101-8
87. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, et al. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100:1885-90
88. Hillyer P, Male D. 2005. Expression of chemokines on the surface of different human endothelia. Immunol. Cell Biol. 83:375-82
89. Proebstl D, Voisin MB,Woodfin A,Whiteford J, D'Acquisto F, et al. 2012. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 209:1219-34
90. StarkK,Eckart A,Haidari S,Tirniceriu A, LorenzM, et al. 2013. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat. Immunol. 14:41-51
91. Kim ND, Chou RC, Seung E, Tager AM, Luster AD. 2006. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J. Exp. Med. 203:829-35
92. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, et al. 2006. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203:837-42
93. Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, et al. 2010. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33:266-78
94. McDonald B, Pittman K, MenezesGB, Hirota SA, Slaba I, et al. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-66
95. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104-7
96. Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, et al. 2008. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat. Immunol. 9:743-52
97. Afonso PV, Janka-Junttila M, Lee YJ, McCann CP, Oliver CM, et al. 2012. LTB4 is a signal-relay molecule during neutrophil chemotaxis. Dev. Cell 22:1079-91
98. Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, et al. 2013. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498:371-75
99. Das ST, Rajagopalan L, Guerrero-Plata A, Sai J, Richmond A, et al. 2010. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS ONE 5:e11754
100. Bennouna S, Bliss SK, Curiel TJ,Denkers EY. 2003. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells duringmicrobial infection. J. Immunol. 171:6052-58
101. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, et al. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94:12053-58
102. Palframan RT, Jung S, Cheng G,WeningerW, Luo Y, et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-73
103. Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, et al. 2011. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 34:590-601
104. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, et al. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-23
105. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13:587-96
106. Weber C, Weber KS, Klier C, Gu S, Wank R, Horuk R, Nelson PJ. 2001. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+ T cells. Blood 97:1144-46
107. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, et al. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24:191-201
108. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, et al. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-70
109. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, et al. 2009. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113:963-72
110. Moatti D, Faure S, Fumeron F, Amara MelW, Seknadji P, et al. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-28
111. Menzies-Gow A, Robinson DS. 2001. Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets. J. Asthma: Off. J. Assoc. Care Asthma 38:605-13
112. Humbles AA, Lu B, Friend DS,Okinaga S, Lora J, et al. 2002. Themurine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA 99:1479-84
113. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433-44
114. Kalomenidis I, Stathopoulos GT, Barnette R, Guo Y, Peebles RS, et al. 2005. Eotaxin-3 and interleukin- 5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Chest 127:2094-100
115. Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME. 2005. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J. Immunol. 175:5341-50
116. Wong CK, Hu S, Cheung PF, Lam CW. 2010. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am. J. Respir. Cell Mol. Biol. 43:305-15
117. Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, et al. 1999. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162:4903-9
118. Yan S, Gessner R, Dietel C, Schmiedek U, Fan H. 2012. Enhanced ovalbumin-induced airway inflammation in CD26 mice. Eur. J. Immunol. 42:533-40
119. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, et al. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760-69
120. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, et al. 2013. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339:328-32
121. Tal O, Lim HY, Gurevich I, Milo I, Shipony Z, et al. 2011. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208:2141-53
122. Pflicke H, Sixt M. 2009. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206:2925-35
123. Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, et al. 2009. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 10:394-402
124. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, et al. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2:e49
125. Hokeness KL, KuzielWA, Biron CA, Salazar-Mather TP. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174:1549-1556
126. Hancock WW, GaoW, Csizmadia V, Faia KL, Shemmeri N, et al. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193:975-980
127. Wald O, Weiss ID, Wald H, Shoham H, Bar-Shavit Y, et al. 2006. IFN-γacts on T cells to induce NK cell mobilization and accumulation in target organs. J. Immunol. 176:4716-29
128. Wehr A, Baeck C,Heymann F, Niemietz PM,Hammerich L, et al. 2013. Chemokine receptor CXCR6- dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J. Immunol. 190:5226-5236
129. HuangD, Shi F-D, Jung S, Pien GC,Wang J, et al. 2006. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20:896-905
130. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL. 2010. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 207:1907-1921
131. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, et al. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25:989-1001
132. Graw F, Regoes RR. 2012. Influence of the fibroblastic reticular network on cell-cell interactions in lymphoid organs. PLoS Comput. Biol. 8:e1002436
133. Okada T, Cyster JG. 2007. CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node. J. Immunol. 178:2973-78
134. Worbs T, Mempel TR, Bolter J, von Andrian UH, Forster R. 2007. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J. Exp. Med. 204:489-95
135. Schumann K, Lammermann T, BrucknerM, Legler DF, Polleux J, et al. 2010. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32:703-13
136. Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694-701
137. Huang JH, Cardenas-Navia LI, Caldwell CC, Plumb TJ, Radu CG, et al. 2007. Requirements for T lymphocyte migration in explanted lymph nodes. J. Immunol. 178:7747-55
138. Yi T, Wang X, Kelly LM, An J, Xu Y, et al. 2012. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37:535-48
139. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. 2006. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440:890-95
140. Hugues S, Scholer A, Boissonnas A, Nussbaum A, Combadiere C, et al. 2007. Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat. Immunol. 8:921-30
141. Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, et al. 2010. Alternative crosspriming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat. Immunol. 11:313-20
142. Friedman RS, Jacobelli J, KrummelMF. 2006. Surface-bound chemokines capture and prime T cells for synapse formation. Nat. Immunol. 7:1101-8
143. Gerard A, Khan O, Beemiller P, Oswald E,HuJ, et al. 2013. SecondaryTcell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells. Nat. Immunol. 14:356-63
144. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, et al. 2011. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J. Exp. Med. 208:2511-24
145. KastenmullerW, Brandes M, Wang Z, Herz J, Egen JG, Germain RN. 2013. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38:502-13
146. Ferguson AR, Engelhard VH. 2010. CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors. J. Immunol. 184:4079-86
147. Kurachi M, Kurachi J, Suenaga F, Tsukui T, Abe J, et al. 2011. Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp. Med. 208:1605-20
148. Kohlmeier JE, Reiley WW, Perona-Wright G, Freeman ML, Yager EJ, et al. 2011. Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection. J. Exp. Med. 208:1621-34
149. Hu JK, Kagari T, Clingan JM, Matloubian M. 2011. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proc. Natl. Acad. Sci. USA 108:E118-27
150. Bromley SK, Mempel TR, Luster AD. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9:970-80
151. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-83
152. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, et al. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 37:1091-103
153. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. 2012. A spatiallyorganized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150:1235-48
154. Groom JR, Luster AD. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89:207-15
155. Oghumu S, Dong R, Varikuti S, Shawler T, Kampfrath T, et al. 2013. Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse. J. Immunol. 190:2229-40
156. Bajenoff M, Breart B, Huang AY, Qi H, Cazareth J, et al. 2006. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203:619-31
157. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, et al. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γfor TH1 priming. Nat. Immunol. 5:1260-65
158. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, et al. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16:915-28
159. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. 2001. Mice lacking expression of the chemokines CCL21-Ser and CCL19 ( plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193:207-18
160. Guarda G, Hons M, Soriano SF, Huang AY, Polley R, et al. 2007. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 8:743-52
161. Leon B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, Lund FE. 2012. Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat. Immunol. 13:681-90
162. Tang HL, Cyster JG. 1999. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284:819-22
163. Alferink J, Lieberam I, Reindl W, Behrens A, Weiss S, et al. 2003. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 197:585-99
164. Baekkevold ES,Wurbel MA, Kivisakk P, Wain CM, Power CA, et al. 2005. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J. Exp. Med. 201:1045-51
165. Reif K, Ekland EH, Ohl L,NakanoH, LippM, et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94-99
166. Pereira JP, Kelly LM, Xu Y, Cyster JG. 2009. EBI2 mediates B cell segregation between the outer and centre follicle. Nature 460:1122-26
167. OkadaT,MillerMJ, Parker I, KrummelMF, NeighborsM, et al. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3:e150
168. Green JA, Suzuki K, Cho B,Willison LD, Palmer D, et al. 2011. The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat. Immunol. 12:672-80
169. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, et al. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5:943-52
170. Victora GD, Nussenzweig MC. 2012. Germinal centers. Annu. Rev. Immunol. 30:429-57
171. Cyster JG, Schwab SR. 2012. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30:69-94
172. Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG. 2008. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28:122-33
173. Nolz JC, Starbeck-Miller GR, Harty JT. 2011. Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy 3:1223-33
174. Hess C, Means TK, Autissier P, Woodberry T, Altfeld M, et al. 2004. IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 104:3463-71
175. Lim HW, Lee J, Hillsamer P, Kim CH. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180:122-29
176. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10:857-63
177. Kara EE, Comerford I, BastowCR, FenixKA, LitchfieldW, et al. 2013. Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. J. Immunol. 191:1110-17
178. Zhou L, Chong MM, Littman DR. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-55
179. Freeman CM, Stolberg VR, Chiu BC, Lukacs NW, Kunkel SL, Chensue SW. 2006. CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses. J. Immunol. 177:4149-58
180. Nakanishi Y, Lu B, Gerard C, Iwasaki A. 2009. CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help. Nature 462:510-13
181. Agace WW. 2006. Tissue-tropic effector T cells: generation and targeting opportunities. Nat. Rev. Immunol. 6:682-92
182. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. 2004. Retinoic acid imprints guthoming specificity on T cells. Immunity 21:527-38
183. Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, et al. 2006. Gut-Associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 107:3447-54
184. Mora JR,Cheng G, Picarella D, BriskinM, BuchananN, von AndrianUH.2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-Associated lymphoid tissues. J. Exp. Med. 201:303-16
185. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, et al. 2007. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8:285-93
186. McCully ML, Ladell K, Hakobyan S, Mansel RE, Price DA, Moser B. 2012. Epidermis instructs skin homing receptor expression in human T cells. Blood 120:4591-98
187. Galkina E, Thatte J, Dabak V,WilliamsMB, Ley K, Braciale TJ. 2005. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J. Clin. Investig. 115:3473-83
188. Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L, Farber DL. 2011. Cutting edge: Tissueretentive lungmemoryCD4Tcells mediate optimal protection to respiratory virus infection. J. Immunol. 187:5510-14
189. Mikhak Z, Strassner JP, Luster AD. 2013. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J. Exp. Med. 210:1855-69
190. Ruane D, Brane L, Reis BS, Cheong C, Poles J, et al. 2013. Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J. Exp. Med. 210:1871-88
191. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-17
192. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101-5
193. Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS. 2006. Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity 25:511-20
194. Harris TH, Banigan EJ, Christian DA, Konradt C, Tait Wojno ED, et al. 2012. Generalized Levy walks and the role of chemokines in migration of effector CD8+ T cells. Nature 486:545-48
195. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, et al. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12:483-94
196. Mionnet C, Buatois V, Kanda A, Milcent V, Fleury S, et al. 2010. CX3CR1 is required for airway inflammation by promoting T helper cell survival andmaintenance in inflamed lung. Nat. Med. 16:1305-12
197. Bromley SK, Thomas SY, Luster AD. 2005. Chemokine receptorCCR7guidesTcell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6:895-901
198. DebesGF, Arnold CN,Young AJ, Krautwald S, Lipp M, et al. 2005. Chemokine receptorCCR7required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6:889-94
199. Jennrich S, Lee MH, Lynn RC, Dewberry K, Debes GF. 2012. Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lung. J. Virol. 86:3436-45
200. BrownMN, Fintushel SR, LeeMH, Jennrich S, Geherin SA, et al. 2010. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 185:4873-82
201. Ledgerwood LG,Lal G, ZhangN,Garin A, Esses SJ, et al. 2008. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissueTlymphocytes into afferent lymphatics. Nat. Immunol. 9:42-53
202. Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, et al. 2011. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118:6220-29
203. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12
204. Scimone ML, Felbinger TW, Mazo IB, Stein JV, Von Andrian UH, Weninger W. 2004. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J. Exp. Med. 199:1113-20
205. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, et al. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150:1249-63
206. Martin-Fontecha A, Baumjohann D, Guarda G, Reboldi A, Hons M, et al. 2008. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J. Exp. Med. 205:2561-74
207. Brinkman CC, Rouhani SJ, Srinivasan N, Engelhard VH. 2013. Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells. J. Immunol. 191:2412-25
208. Mueller SN, Gebhardt T, Carbone FR, Heath WR. 2013. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31:137-61
209. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, et al. 2013. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14:1294-301
210. Skon CN, Lee J, Anderson KG,Masopust D,Hogquist KA, et al. 2013. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 14:1285-93
211. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, et al. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477:216-19
212. Ariotti S, Beltman JB, Chodaczek G, Hoekstra ME, van Beek AE, et al. 2012. Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc. Natl. Acad. Sci. USA 109:19739-44
213. Bromley SK, Yan S, Tomura M, Kanagawa O, Luster AD. 2013. Recirculating memory T cells are a unique subset of CD4+ T cells with a distinct phenotype and migratory pattern. J. Immunol. 190:970-76
214. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10:524-30
215. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. 2012. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature 483:227-31
216. Strutt TM,McKinstry KK, Dibble JP, Winchell C, Kuang Y, et al. 2010. Memory CD4+ T cells induce innate responses independently of pathogen. Nat. Med. 16:558-64
217. Schenkel JM, Fraser KA, Vezys V, Masopust D. 2013. Sensing and alarm function of resident memory CD8+ T cells. Nat. Immunol. 14:509-13
218. Ueha S, Yoneyama H, Hontsu S, KurachiM, KitabatakeM, et al. 2007. CCR7mediates themigration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules. J. Leukoc. Biol. 82:1230-38
219. Smigiel KS, Richards E, Srivastava S, Thomas KR, Dudda JC, et al. 2014. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211:121-36
220. Menning A, Hopken UE, Siegmund K, Lipp M, Hamann A, Huehn J. 2007. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur. J. Immunol. 37:1575-83
221. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. 2007. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 204:735-45
222. Afshar R, Strassner JP, Seung E, Causton B, Cho JL, et al. 2013. Compartmentalized chemokinedependent regulatory T-cell inhibition of allergic pulmonary inflammation. J. Allergy Clin. Immunol. 131:1644-52
223. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. 2002. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-65
224. Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, et al. 2004. L-selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104:3804-12
225. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7:652-62
226. Yuan Q, Bromley SK, Means TK, Jones KJ, Hayashi F, et al. 2007. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204:1327-34
227. Pace L, Tempez A, Arnold-Schrauf C, Lemaitre F, Bousso P, et al. 2012. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 338:532-36
228. Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, et al. 2006. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203:505-11
229. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, et al. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7:83-92
230. Lund JM, Hsing L, Pham TT, Rudensky AY. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220-24
231. Sarween N, Chodos A, Raykundalia C, Khan M, Abbas AK, Walker LS. 2004. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173:2942-51
232. Chung Y,Tanaka S, Chu F, Nurieva RI,Martinez GJ, et al. 2011. Follicular regulatoryTcells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17:983-88
233. Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, et al. 2011. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17:975-82
234. Bystry RS, Aluvihare V, Welch KA,KallikourdisM, Betz AG. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2:1126-32
235. Lee JH, Kang SG, Kim CH. 2007. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178:301-11
236. Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA. 2006. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203:2451-60
237. Moreira AP, Cavassani KA, Massafera Tristao FS, Campanelli AP, Martinez R, et al. 2008. CCR5- dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J. Immunol. 180:3049-56
238. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, et al. 2005. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 106:3300-7
239. Coghill JM, Fowler KA, West ML, Fulton LM, van Deventer H, et al. 2013. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease. Blood 122:825-36
240. Zhang N, Schroppel B, Lal G, Jakubzick C, Mao X, et al. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30:458-69
241. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595-602
242. Hall AO, Beiting DP, Tato C, John B, Oldenhove G, et al. 2012. The cytokines interleukin 27 and interferon-gamma promote distinctTreg cell populations required to limit infection-induced pathology. Immunity 37:511-23
243. MullerM,Carter SL, HoferMJ, Manders P,Getts DR, et al. 2007.CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 179:2774-86
244. Erhardt A, Wegscheid C, Claass B, Carambia A, Herkel J, et al. 2011. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. J. Immunol. 186:5284-93
245. Duhen T, Duhen R, Lanzavecchia A, Sallusto F, Campbell DJ. 2012. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119:4430-40
246. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, et al. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:351-56
247. Faustino L, da Fonseca DM, Takenaka MC, Mirotti L, Florsheim EB, et al. 2013. Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J. Immunol. 190:2614-21
248. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, et al. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986-91
249. Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, et al. 2008. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181:8391-401
250. Barth T, Schmidt D, Botteron C, Nguyen TT, Ritter U, et al. 2012. An early reduction in Treg cells correlates with enhanced local inflammation in cutaneous leishmaniasis in CCR6-deficient mice. PLoS ONE 7:e44499
251. Iellem A,MarianiM, Lang R, RecaldeH, Panina-Bordignon P, et al. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 194:847-53
252. Siewert C,Menning A, Dudda J, Siegmund K, Lauer U, et al. 2007. Induction of organ-selective CD4+ regulatory T cell homing. Eur. J. Immunol. 37:978-89
253. Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, et al. 2011. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology 141:2109-18
254. Walters MJ, Ebsworth K, Sullivan TJ, Zhang P, Powers JP, et al. 2013. CCR9 inhibition does not interfere with the development of immune tolerance to oral antigens. Immunol. Lett. 151:44-47
255. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK. 2011. Response to self antigen imprints regulatory memory in tissues. Nature 480:538-42
256. Bachelerie FB-BA, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, et al. 2014. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66:1-79